Sara Duncan
Family Medicine · Carriere, MSNPI 1285108662
Payments from drug & device makers
Across 193 payments — averaging $16.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$695
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$383
- Corium, LLC$291
- Takeda Pharmaceuticals U.S.A., Inc.$217
- Pfizer$189
- Ironshore Pharmaceuticals Inc.$175
- plus $1K from 24 others
What the payments were for
- Food & beverage$3,216100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 52 | $695 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 25 | $383 |
| Corium, LLC | 15 | $291 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $217 |
| Pfizer | 10 | $189 |
| Ironshore Pharmaceuticals Inc. | 14 | $175 |
| AstraZeneca | 6 | $159 |
| Avanir Pharmaceuticals, Inc. | 8 | $135 |
| Otsuka America Pharmaceutical, Inc. | 7 | $124 |
| Neurocrine Biosciences, Inc. | 4 | $118 |
| Biogen | 6 | $116 |
| Axsome Therapeutics, Inc. | 4 | $99 |
| Amgen | 4 | $66 |
| Vanda Pharmaceuticals Inc. | 3 | $55 |
| Bayer | 3 | $50 |
| Lilly USA, LLC | 3 | $47 |
| Daiichi Sankyo Inc. | 2 | $42 |
| Lundbeck LLC | 2 | $36 |
| Inspire Medical Systems, Inc. | 1 | $28 |
| Indivior Inc. | 1 | $27 |
| Kerecis Limited | 1 | $24 |
| Tris Pharma Inc | 1 | $20 |
| Novartis | 1 | $20 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Noven Therapeutics, LLC | 1 | $15 |
| Johnson & Johnson | 1 | $14 |
| Biohaven Pharmaceuticals, Inc. | 1 | $14 |
| Astellas Pharma US Inc | 1 | $13 |
| Supernus Pharmaceuticals, Inc. | 1 | $13 |
| GSK | 1 | $12 |
How this compares
$3,216 in reported general payments places this provider in the 75th percentile of 971 family medicine providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 44 | $64,960 |
| JardianceEmpagliflozin | 55 | $53,851 |
| OzempicSemaglutide | 29 | $35,771 |
| EliquisApixaban | 24 | $35,231 |
| TrulicityDulaglutide | 22 | $33,760 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 22 | $18,064 |
| FarxigaDapagliflozin Propanediol | 16 | $16,648 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 12 | $13,996 |
| RybelsusSemaglutide | 12 | $11,343 |
| XareltoRivaroxaban | 14 | $8,871 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 21 | $3,450 |
| Novolin 70-30Insulin Nph Hum/Reg Insulin Hm | 17 | $3,203 |
| LantusInsulin Glargine,hum.Rec.Anlog | 16 | $2,034 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 69 | $1,870 |
| Atorvastatin Calcium | 204 | $1,536 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro, Trulicity | $47 | $98,72066 claims |
| PfizerEliquis | $189 | $35,23124 claims |
| AstraZenecaFarxiga | $159 | $16,64816 claims |
| GSKTrelegy Ellipta | $12 | $13,99612 claims |
| Johnson & JohnsonXarelto | $14 | $8,87114 claims |
| AbbVieSynthroid | $695 | $78913 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 971 family medicine providers in Mississippi.
Other family medicine in Carriere
- Paul MatherneGulfport$14.4M
- Timothy QuinnRidgeland$8M
- Sean KerbyGulfport$6.6M
- Rambod RouhbakhshHattiesburg$6M
- Randall HulingOlive Branch$4.6M
- Demetri MarshallPort Gibson$3M
- Alexander OsowaJackson$2.2M
- Russell CarlisleWesson$1.6M
- Kristi TrimmRidgeland$1.2M
- Keith StokesLexington$660K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.